Workflow Services’ Momentum 100 Days into FDA’s Point-of-Care Delivery Initiative at Pharmacies

MADISON, Wis., Feb. 28, 2024 – Workflow Services, a comprehensive and automated platform that solves point-of-care clinical service delivery for pharmacies, marked a major milestone in its partnership with the FDA in its groundbreaking Diagnostic Data Program. 

In the 100 days since the FDA selected Workflow Services as its partner to collect data from point-of-care tests administered across U.S. pharmacies, Workflow Services has grown the footprint of users on its platform, built partnerships with industry trade organizations and test manufacturers, and added talent to its team to accelerate the mission of making pharmacists a key player in local healthcare delivery. 

Fully realized, the FDA Program’s aim of de-identified data collection and transmission will aid federal and state public health leaders in making evidence-based decisions from a regulatory as well as population health standpoint. Access to diagnostic testing data provides early, and actionable information related to viruses’ location and spread—vital information that can empower proactive, targeted intervention to minimize transmission and suppress outbreaks. 

“We are growing and adding a wealth of industry knowledge and understanding of market trends, enabling us to be a stronger, more receptive, and agile partner to our pharmacy customers,” said Elise Miller Hoffman, COO of Workflow Services and ImageMover. 

Read the full 100-day update here. 

Learn more about Workflow Services' partnership with the FDA, where you can sign up for regular updates.